We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
+7.15%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.02%
AUM
$150B
AUM Growth
+$12.9B
Cap. Flow
+$4.72B
Cap. Flow %
3.14%
Top 10 Hldgs %
14.8%
Holding
3,187
New
75
Increased
2,456
Reduced
443
Closed
56

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$175M
2
INTC icon
Intel
INTC
+$154M
3
AMZN icon
Amazon
AMZN
+$115M
4
IBM icon
IBM
IBM
+$97.2M
5
PLD icon
Prologis
PLD
+$92.2M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$156M
2
GGP
GGP Inc.
GGP
+$135M
3
TSM icon
TSMC
TSM
+$111M
4
DCT
DCT Industrial Trust Inc.
DCT
+$81.8M
5
XL
XL Group Ltd.
XL
+$59.6M

Sector Composition

Rank Sector Weight
1 Technology 16.59%
2 Financials 14.04%
3 Healthcare 13.2%
4 Industrials 10.93%
5 Consumer Discretionary 10.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CUE icon
3001
Cue Biopharma
CUE
$110M
$300K ﹤0.01%
1,103
SGA icon
3002
Saga Communications
SGA
$61.4M
$300K ﹤0.01%
8,286
+1,886
+29% +$70K
PMBC
3003
DELISTED
Pacific Mercantile Bancorp
PMBC
$299K ﹤0.01%
31,939
+139
+0.4% +$1.37K
PBIP
3004
DELISTED
Prudential Bancorp, Inc.
PBIP
$298K ﹤0.01%
17,200
MBCN
3005
DELISTED
Middlefield Banc Corp
MBCN
$297K ﹤0.01%
12,588
-12
-0.1% -$297
CLUB
3006
DELISTED
Town Sports International Holdings, Inc.
CLUB
$296K ﹤0.01%
34,175
RJET
3007
Republic Airways Holdings
RJET
$946M
$294K ﹤0.01%
+1,414
New +$288K
IRMD icon
3008
iRadimed
IRMD
$1.15B
$292K ﹤0.01%
+7,834
New +$211K
FFNW
3009
DELISTED
First Financial Northwest, Inc
FFNW
$292K ﹤0.01%
17,567
+2,467
+16% +$44.9K
ITI
3010
DELISTED
Iteris, Inc.
ITI
$292K ﹤0.01%
54,275
+12,975
+31% +$66K
EVLO
3011
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$292K ﹤0.01%
1,198
+69
+6% +$18.1K
SYRE icon
3012
Spyre Therapeutics
SYRE
$9.29B
$290K ﹤0.01%
1,212
FCCY
3013
DELISTED
1st Constitution Bancorp
FCCY
$290K ﹤0.01%
14,000
FUNC icon
3014
First United
FUNC
$287M
$288K ﹤0.01%
15,275
ASTH icon
3015
Astrana Health
ASTH
$1.86B
$288K ﹤0.01%
13,006
-33,194
-72% -$699K
GNK icon
3016
Genco Shipping & Trading
GNK
$1.09B
$287K ﹤0.01%
20,474
+4,700
+30% +$66.4K
PLSE icon
3017
Pulse Biosciences
PLSE
$2.96B
$283K ﹤0.01%
19,900
+4,500
+29% +$63.9K
SB icon
3018
Safe Bulkers
SB
$764M
$282K ﹤0.01%
97,600
MRSN
3019
DELISTED
Mersana Therapeutics
MRSN
$281K ﹤0.01%
1,124
+144
+15% +$48.3K
PEBK icon
3020
Peoples Bancorp of North Carolina
PEBK
$228M
$280K ﹤0.01%
9,677
+1,427
+17% +$43.8K
GDP
3021
DELISTED
Goodrich Petroleum Corporation Common Stock
GDP
$277K ﹤0.01%
19,669
+3,169
+19% +$41K
KEG
3022
DELISTED
Key Energy Services, Inc. Common Stock
KEG
$275K ﹤0.01%
24,001
+6,401
+36% +$93.5K
NEOS
3023
DELISTED
Neos Therapeutics, Inc
NEOS
$273K ﹤0.01%
56,200
ADMA icon
3024
ADMA Biologics
ADMA
$2.18B
$272K ﹤0.01%
43,700
+8,300
+23% +$47.8K
VIVS
3025
VivoSim Labs
VIVS
$1.27M
$271K ﹤0.01%
980
-973
-50% -$293K

Similar funds

Charles Schwab's Q3 2018 Portfolio in Review

As of Q3 2018, Charles Schwab held 3,187 positions worth $150B, up 9.4% from $137B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Charles Schwab deployed $4.72B of net new capital in Q3 2018, opening 75 new positions and adding to 2,456 existing holdings. Its largest new stake was KKR & Co: 895,988 shares worth $24.4M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Apple, an estimated $156M trimmed.

  • Charles Schwab's largest Q3 2018 buy was KKR & Co: 895,988 shares worth $24.4M.
  • Charles Schwab added most to Microsoft in Q3 2018, an estimated $175M increase.
  • Charles Schwab's biggest Q3 2018 reduction was Apple, cutting an estimated $156M.
  • Charles Schwab fully exited GGP Inc. in Q3 2018, selling an estimated $135M.
  • Charles Schwab's ten largest holdings make up 15% of its $150B portfolio in Q3 2018.
  • Charles Schwab opened 75 new positions and closed 56 in Q3 2018.
  • Charles Schwab's portfolio value rose 9.4% quarter-over-quarter to $150B.

Based on Charles Schwab's 13F filing for Q3 2018, filed 13 Nov 2018.